Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine: follow-up from months 12-24 in a Phase III randomized study of healthy women aged 18-45 years (Q35918834)
Jump to navigation
Jump to search
scientific article published in December 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine: follow-up from months 12-24 in a Phase III randomized study of healthy women aged 18-45 years |
scientific article published in December 2011 |
Statements
1 reference
Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine: follow-up from months 12-24 in a Phase III randomized study of healthy women aged 18-45 years (English)
1 reference
1 reference
human papillomavirus
29 September 2024
Myron J Levin
1 reference
Mark H Einstein
1 reference
Mira Baron
1 reference
Archana Chatterjee
1 reference
Bradley Fox
1 reference
Sofia Scholar
1 reference
Jeffrey Rosen
1 reference
Nahida Chakhtoura
1 reference
Dorothée Meric
1 reference
Francis J Dessy
1 reference
Sanjoy K Datta
1 reference
Dominique Descamps
1 reference
Gary Dubin
1 reference
HPV-010 Study Group
1 reference
1 December 2011
1 reference
1 reference
1343-1358
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference